biote Corp. (BTMD)
NASDAQ: BTMD · Real-Time Price · USD
1.330
+0.020 (1.53%)
At close: Sep 11, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Sep 11, 2026, 7:30 PM EDT
biote Revenue
biote had revenue of $44.23M in the quarter ending June 30, 2026, a decrease of -9.48%. This brings the company's revenue in the last twelve months to $183.53M, down -7.81% year-over-year. In the year 2025, biote had annual revenue of $192.22M, down -2.52%.
Revenue (ttm)
$183.53M
Revenue Growth
-7.81%
P/S Ratio
0.25
Revenue / Employee
$823,009
Employees
223
Market Cap
45.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 192.22M | -4.97M | -2.52% |
| Dec 31, 2024 | 197.19M | 11.83M | 6.38% |
| Dec 31, 2023 | 185.36M | 20.40M | 12.37% |
| Dec 31, 2022 | 164.96M | 25.56M | 18.34% |
| Dec 31, 2021 | 139.40M | 22.83M | 19.58% |
| Dec 31, 2020 | 116.57M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| P3 Health Partners | 1.50B |
| Auna S.A. | 1.37B |
| WW International | 665.49M |
| DocGo | 294.72M |
| Park Dental Partners | 251.37M |
| AirSculpt Technologies | 150.72M |
| Concord Medical Services Holdings | 65.84M |
| The Joint | 58.55M |
BTMD News
- 4 weeks ago - Biote price target lowered to $1.50 from $2 at B. Riley - TheFly
- 5 weeks ago - Biote price target lowered to $2 from $2.50 at TD Cowen - TheFly
- 5 weeks ago - Biote price target lowered to $2.50 from $3 at Roth Capital - TheFly
- 5 weeks ago - Biote reports Q2 EPS (23c) vs 10c last year - TheFly
- 5 weeks ago - Biote sees FY26 revenue above $175M, consensus $190.61M - TheFly
- 5 weeks ago - biote Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - biote Earnings release: Q2 2026 - Filings
- 5 weeks ago - biote Quarterly report: Q2 2026 - Filings